You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

 

Online download statistics by month:

Online download statistics by month: May 2023 to July 2025

AbstractFullPdf
May 2023384385102
Jun 202325926096
Jul 202317717958
Aug 202317317543
Sep 202311411445
Oct 202310710755
Nov 202313013132
Dec 202322622744
Jan 20246363105
Feb 2024909226
Mar 202412712840
Apr 202410410435
May 2024696939
Jun 2024919041
Jul 2024919549
Aug 20241009728
Sep 2024666736
Oct 2024626337
Nov 2024838424
Dec 2024717419
Jan 2025757733
Feb 202520420425
Mar 2025898929
Apr 202511411432
May 2025848534
Jun 2025484836
Jul 2025110
Total320232221143